Production at bedeviled baby formula factory halted by storm
Severe weather has forced Abbott Nutrition to pause production at a Michigan baby formula factory that had just restarted
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Severe weather has forced Abbott Nutrition to pause production at a Michigan baby formula factory that had just restarted after being closed for several months.
The facility is closely tied to the recent baby formula shortage.
Production for its EleCare specialty formula has been suspended, but there is enough supply to meet demand until production is restarted, the company said. The company put a priority on ramping up production of the specialty formula for infants with severe food allergies and digestive problems who have few other options for nutrition.
Abbott says it needs to assess damage and re-sanitize the factory after severe thunderstorms and heavy rains swept through southwestern Michigan late Monday. The company didn’t indicate how much damage the factory sustained.
Abbott had restarted the Sturgis, Michigan, factory on June 4 after it had been closed since February due to contamination.
The factory was closed after the Food and Drug Administration began investigating four bacterial infections among infants who consumed powdered formula from the plant. Two of the babies died. The company continues to state that its products have not been directly linked to the infections, which involved different bacterial strains.
FDA inspectors eventually uncovered a host of violations at the plant, including bacterial contamination, a leaky roof and lax safety protocols.
Abbott recalled several leading brands of formula in February, including Similac. That squeezed squeezed supplies that had already been strained by supply chain disruptions and stockpiling during COVID-19 shutdowns.
The company offered no time frame in its statement for when production will resume.